Teva is back: returned to being the largest company in terms of market value in Israel :: Israeli Financial News - The Israeli Economic World
Business in Brief: Teva Pharm to Move Headquarters to Tel Aviv - Business - Haaretz.com
Teva will move North American HQ to New Jersey - Kansas City Business Journal
Teva to build new headquarters in Tel Aviv - Globes
Teva relocates headquarters in Israel
Teva lied about opioid role, New York says | Reuters
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Israeli authorities cut Teva some slack as foreign bribery case resolved amid other big problems | Fierce Pharma
Israeli drugmaker Teva to cut quarter of global work force (Update)
Just 10% of Teva's employees located in Israel - Globes
Jerusalem, Israel. 21st Oct, 2019. The Teva Pharmaceutical logo is seen in English and Hebrew at their tablet production plant in Jerusalem, on Monday, October 21, 2019. The Israeli drug manufacturer Teva's
Teva said to 'walk away' from settlement talks in US price-fixing lawsuit | The Times of Israel
Teva Chooses New Israeli Headquarters in Tel Aviv | Ctech
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva's Deal for Mylan Shows Corporate Israel's M&A Hunger - WSJ
Teva Pharmaceutical in $4.35 opioid settlement with states, Native American tribes (TEVA) | Seeking Alpha
Teva Pharmaceutical Initiated at Market Perform at BMO - TheStreet
Allergan sells generic drug unit to Israel's Teva for $40.5 billion - Los Angeles Times
Top Teva exec says company picked N.J. because of its 'value,' history in life sciences | ROI-NJ
Teva shares plunge as competitors get nod for copycat flagship drug | The Times of Israel
Teva to be Sole Distributor of COVID-19 Vaccines in Israel | The Jewish Press - JewishPress.com | Hana Levi Julian | 21 Kislev 5781 – December 6, 2020 | JewishPress.com
Teva Pharmaceuticals Office Photos | Glassdoor
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
TEVA stock on watch as CEO comments on opioid deal (NYSE:TEVA) | Seeking Alpha
